Vanguard Group Inc Cocrystal Pharma, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $1 - $14	-4 Reduced -0.0%	3,255,081 $948,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.55 $6,670 - $9,654	-17,553 Reduced 0.54%	3,255,085 $1.34 Million
Q1 2022 May 13, 2022	SELL	$0.48 - $0.71 $5,070 - $7,499	-10,563 Reduced 0.32%	3,272,638 $1.8 Million
Q4 2021 Feb 14, 2022	SELL	$0.65 - $1.02 $2,469 - $3,874	-3,799 Reduced 0.12%	3,283,201 $2.13 Million
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.25 $185,804 - $229,956	183,965 Added 5.93%	3,287,000 $3.45 Million
Q2 2021 Aug 13, 2021	BUY	$1.08 - $2.14 $3.35 Million - $6.64 Million	3,103,035 New	3,103,035 $3.88 Million

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.